Monash IVF Group (MVF) H1 2026 earnings summary

Executive summary

• Underlying NPAT for 1H26 was $10.4 million, down 34% year-over-year but at the upper end of guidance, with revenue at $137.9 million, a 1.8% decrease, reflecting stabilization and operational reset amid CEO and CFO transitions.

• Clinical pregnancy rates improved to 40.7% for women under 43, with strong performance in younger cohorts.

• Market share in stimulated cycles declined to 19%, with volumes down 11.7% year-over-year, impacted by increased competition and flat new patient registrations.

• Major infrastructure cycle concluding with new Brisbane Clinic and Day Hospital opening in Q4 FY26, positioning for improved capital efficiency and organic margin growth.

• Strategic focus on restoring core performance, margin growth, and leadership alignment, with operational stability returning after prior disruptions.

Financial highlights

• Revenue for the half was $137.9 million, down 1.8% year-over-year, with underlying EBITDA of $30.2 million (margin 22%), and reported NPAT of $7.5 million, down 56.4%.

• Free cash flow improved to $5 million from negative $6.2 million in the prior period.

• Net debt increased to $95–96.2 million, leverage ratio at 2.0x, and net debt to equity ratio at 36.8–37.4%.

• Interim fully franked dividend of 1.2 cents per share declared.

• Group underlying EBITDA margin was 19.0%, impacted by negative volume leverage and no price increases in key markets.

Outlook and guidance

• FY26 underlying NPAT guidance reaffirmed at $20 million, with full-year capital expenditure expected at $16–17 million as major infrastructure projects complete in Q4FY26.

• Dividend payout policy remains at 60–70% of full-year underlying earnings.

• Net leverage ratio expected to remain at 2.0x, well below covenant limits.

• Anticipated patient price increases and operational efficiency expected to drive earnings and margin growth in FY27, with industry growth expected to return and early signs of patient activity recovery.

• Strategic initiatives underway to restore performance in Victoria and New South Wales, with both short-term and long-term levers.